DaVita Inc. $DVA Stock Holdings Lifted by Iron Triangle Partners LP

Key Points

• Iron Triangle Partners LP increased its stake in DaVita Inc. by 22.7%, acquiring an additional 59,142 shares, making it the firm's biggest holding.
• Institutional investors collectively own 90.12% of DaVita Inc., with other firms also boosting their positions significantly during the first quarter of the year.
• Analysts have mixed views on DaVita, with Wall Street Zen upgrading the stock to a "buy," while Truist Financial set a price target of $148.00 and Barclays lowered theirs to $160.00.

Iron Triangle Partners LP boosted its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 22.7% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 319,566 shares of the company's stock after buying an additional 59,142 shares during the period. DaVita makes up approximately 7.8% of Iron Triangle Partners LP's holdings, making the stock its largest holding. Iron Triangle Partners LP owned approximately 0.42% of DaVita worth $48,884,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Invesco Ltd. raised its holdings in DaVita by 3.4% during the 1st quarter. Invesco Ltd. now owns 1,642,947 shares of the company's stock valued at $251,322,000 after buying an additional 53,402 shares during the period. Northern Trust Corp grew its position in DaVita by 20.2% in the 1st quarter. Northern Trust Corp now owns 890,632 shares of the company's stock valued at $136,240,000 after acquiring an additional 149,858 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in DaVita by 14.0% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 466,046 shares of the company's stock valued at $69,697,000 after acquiring an additional 57,386 shares during the last quarter. Epoch Investment Partners Inc. grew its position in DaVita by 10.7% in the 1st quarter. Epoch Investment Partners Inc. now owns 407,921 shares of the company's stock valued at $62,400,000 after acquiring an additional 39,485 shares during the last quarter. Finally, Deutsche Bank AG grew its position in DaVita by 35.2% in the 4th quarter. Deutsche Bank AG now owns 392,422 shares of the company's stock valued at $58,687,000 after acquiring an additional 102,230 shares during the last quarter. Hedge funds and other institutional investors own 90.12% of the company's stock.

Insiders Place Their Bets

In related news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the transaction, the insider directly owned 26,038 shares in the company, valued at $3,905,700. The trade was a 8.28% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.50% of the stock is currently owned by company insiders.

DaVita Stock Down 0.7%

Shares of DVA traded down $0.94 during trading hours on Tuesday, hitting $136.82. The company had a trading volume of 526,210 shares, compared to its average volume of 853,569. The company has a market capitalization of $9.78 billion, a PE ratio of 13.45, a price-to-earnings-growth ratio of 0.99 and a beta of 1.13. The company has a current ratio of 1.39, a quick ratio of 1.34 and a debt-to-equity ratio of 23.18. DaVita Inc. has a one year low of $126.07 and a one year high of $179.60. The company's fifty day moving average price is $139.76 and its two-hundred day moving average price is $142.29.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, topping the consensus estimate of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The firm had revenue of $3.38 billion during the quarter, compared to analyst estimates of $3.36 billion. During the same period in the previous year, the company posted $2.00 EPS. The business's revenue for the quarter was up 6.1% compared to the same quarter last year. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

DVA has been the topic of several research analyst reports. Truist Financial set a $148.00 price objective on DaVita in a research report on Friday, August 8th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research note on Friday, August 22nd. Finally, Barclays decreased their price target on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $164.00.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.